Search

everythinglearnresearchcommunity

for

Search:↓

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Vitamin E helps reduce PCOS symptoms and improves hormonal balance.

Skin issues are common and important for diagnosing PCOS.

PCOS often causes skin issues like excess hair, acne, and hair loss, needing early treatment.

Raising awareness about PCOS can improve women's quality of life.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.